DEPRESSIVE DISORDER, TREATMENT-RESISTANT
Clinical trials for DEPRESSIVE DISORDER, TREATMENT-RESISTANT explained in plain language.
Never miss a new study
Get alerted when new DEPRESSIVE DISORDER, TREATMENT-RESISTANT trials appear
Sign up with your email to follow new studies for DEPRESSIVE DISORDER, TREATMENT-RESISTANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Brain helmet vs. classic coil: new hope for Treatment-Resistant depression
Disease control Recruiting nowThis study compares two types of brain stimulation therapy for people with depression that hasn't responded to standard medications. Participants receive either classic repetitive transcranial magnetic stimulation (rTMS) or a newer 'deep' TMS approach using a helmet-like coil. Th…
Matched conditions: DEPRESSIVE DISORDER, TREATMENT-RESISTANT
Phase: NA • Sponsor: Centre Hospitalier Henri Laborit • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Faster brain zaps tested for elderly depression
Disease control Recruiting nowThis study tests whether giving multiple brain stimulation treatments per day works better than one daily treatment for depression in people aged 60+. All participants receive active treatment, but some get multiple sessions daily for a shorter period while others get one session…
Matched conditions: DEPRESSIVE DISORDER, TREATMENT-RESISTANT
Phase: NA • Sponsor: Centre for Addiction and Mental Health • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
Breakthrough hope: new drug aims to lift depression in days, not weeks
Disease control Recruiting nowThis study is testing whether a new, fast-acting drug called (2R,6R)-HNK can help people with major depression who haven't gotten better with standard treatments. Fifty participants will receive intravenous infusions of either the study drug or a placebo over several weeks to see…
Matched conditions: DEPRESSIVE DISORDER, TREATMENT-RESISTANT
Phase: PHASE2 • Sponsor: National Institute of Mental Health (NIMH) • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New hope for Treatment-Resistant depression: experimental drug trial seeks participants
Disease control Recruiting nowThis study is testing whether an experimental drug called ACP-211 can help adults with major depression who haven't gotten better with standard antidepressant treatments. Researchers will compare ACP-211 against a placebo (inactive pill) to see if it reduces depression symptoms m…
Matched conditions: DEPRESSIVE DISORDER, TREATMENT-RESISTANT
Phase: PHASE2 • Sponsor: ACADIA Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC
-
New nasal spray offers hope for depression patients Who've tried everything else
Symptom relief Recruiting nowThis study is testing whether esketamine nasal spray can help reduce depression symptoms in Korean patients whose depression hasn't improved with at least two standard antidepressant medications. Researchers will measure changes in depression scores over 4 weeks of treatment. The…
Matched conditions: DEPRESSIVE DISORDER, TREATMENT-RESISTANT
Phase: PHASE4 • Sponsor: Janssen Korea, Ltd., Korea • Aim: Symptom relief
Last updated Mar 27, 2026 12:38 UTC
-
Scientists scan brains to unlock Ketamine's depression secret
Knowledge-focused Recruiting nowThis study aims to understand how a single dose of ketamine affects specific brain chemicals in people with depression that hasn't responded to other treatments. Researchers will use MRI brain scans and blood tests to measure changes in chemicals linked to mood, comparing them to…
Matched conditions: DEPRESSIVE DISORDER, TREATMENT-RESISTANT
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC